A Multicenter, Open-Label Safety and Pharmacokinetic Study of DUEXIS (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Phase of Trial: Phase IV
Latest Information Update: 07 Jan 2016
At a glance
- Drugs Ibuprofen/famotidine (Primary)
- Indications Juvenile rheumatoid arthritis; NSAID-induced gastrointestinal damage
- Focus Adverse reactions
- Sponsors Horizon Pharma
- 16 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jul 2014 Planned End Date changed from 1 Apr 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov.